Back
Masterclass - Fundraising in Biotech-Medtech: Instructions for use
March 12th
2024
Raising funds is an important step in the development of a biotech-medtech company. That's why, in collaboration with Altesia, a finance and procurement consultancy, and as part of the Cell and Gene Therapies vol.5 conference organised in partnership with Buzz4bio, we are offering a Masterclass on this topic.
Programme
- 8.00am: Welcome
- 9.00am: Fundraising for a foreign company setting up in Belgium or for a Belgian company wishing to expand locally. Overview of fundraising players (public, private, specialists) - by Gael Claude, Mathieu Delveaux and Cédric Van Themsche (Partners Altesia)
- 9.40am: Point of view of 2 Private Funds - by Alain Parthoens (Newton Biocapital) and Philippe Durieux (Vives Funds)
- 10.20am: Legal aspects of fundraising - by Hadrien Chef (Partner Osborne Clarke)
- 11.00am: Feedback and points of attention on fundraising in Biotech, CMC dossier, etc. (Olivier Favre-Bulle, CEO 3Biotech)
- 11.30am: Round table discussion with (semi-)public funds with Valentin Tonnel (Wallonie Entreprendre), Helena Pozios (Sambrinvest) and Eric Brandt (Noshaq)
- 12.00pm: Q&A session with experienced fundraising CFOs (Virginie Cartage, CFO NOVADIP Biosciences S.A. and Didier Le Normand, CEO NeGIO Therapeutics)
- 12.30pm: Lunch
Date and Time
📆 Date : 12 mars 2024
⏰ Time : 8h à 13h
Location
📍 Van Der Valk Hotel Charleroi Airport
Registration fees
€249 excluding VAT per person, €149 excluding VAT for the second person from the same company
Registration contact
Via Altesia : info@altesia.be